Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated

Abstract

The objective of the study was to analyse the impact of fibromyalgia (FM) on health-related quality of life (HRQOL) and to identify clinical and psychological factors associated with the disease. A cross-sectional study was conducted with adult Portuguese women with FM. Analysed data were demographic, clinical and psychological variables and HRQOL: SF-36 and Fibromyalgia Impact Questionnaire (FIQ). The relationship between HRQOL and the other variables was made with a bivariate analysis. To assess the relative contribution of clinical and psychological variables, a series of multiple regression analyses were designed and made. The study sample consisted of 76 women with FM (49.61 ± 10.07 years). All dimensions of HRQOL were affected in FM, especially Physical Functioning, Physical Role Functioning and General Health. The mean FIQ total score was 68.59 ± 17.54, and 40 patients (53%) presented scores ≥70. Pain intensity, assessed by a 10-cm visual analogue scale (VAS), was a significant predictor of HRQOL in expressing association with FIQ and all dimensions of SF-36, except Emotional Role Functioning. Anxiety (Hospital Anxiety and Depression Scale (HADS)) was a significant predictor of the Mental Component and General Health (SF-36). Depression (HADS) was related with Vitality, Mental Health and FIQ. Emotion-focused coping was related with General Health and Emotional Role Functioning, and social support (Satisfaction with Social Support Scale (ESSS)) was related with the Social Functioning. These clinical and psychological variables explained an acceptable proportion of variability (R (2)), ranging from 31.3% on Emotional Role Functioning to 70.6% on FIQ, except for Physical Role Functioning (R (2) = 6.1). FM has a negative impact on both general and specific dimensions of HRQOL, especially the physical dimensions. Pain intensity, anxiety and depression symptoms and the emotion-focused coping are the most relevant explanatory variables of the impact of FM on HRQOL.

The Relationship between Vitamin D and Quality of Life in Patients with Fibromyalgia Syndrome

“…Using the FIQ and SF-36 forms, Türkyilmaz et al evaluated quality of life in FMS patients and determined a significant difference compared to a control group [58]. Various studies have shown that quality of life was negatively affected in FMS patients [13,14]. Different studies have shown that the quality of life was extremely low compared to control groups in FMS patients with diseases such as rheumatoid arthritis, osteoarthritis, chronic obstructive pulmonary disease and insulin-related diabetes [51].…”

“…The perception and evaluation of the quality of life of individuals is formed from life events in the context of cultural structure and value systems [12]. Several previous studies have shown the quality of life of FMS patients to be negatively affected [13,14].…”

Characterization of the pain, sleep and alexithymia patterns of patients with fibromyalgia treated in a Brazilian tertiary center

“…[1][2][3][4][5] It is the second most common rheumatologic disease, with a worldwide prevalence of 0.5% to 5%. Women aged between 40 and 55 years are predominantly affected, with a prevalence approximately seven fold higher than in men.…”

Efecto de la fibromialgia sobre el estado de salud y la calidad de vida relacionada con la salud, 2004-2014

“…A pesar de que existe un elevado número de investigaciones en CVRS de personas con fibromialgia, los estudios disponibles son diversos en relación con su tipología, es decir, algunos son de validación de las escalas genérica y específica, otros evalúan la CVRS como un desenlace secundario en ensayos clínicos 9 , y entre las investigaciones que analizan el perfil de la CVRS como desenlace primario, se presentan resultados divergentes en cuanto al grado de afectación o impacto de la enfermedad en las dimensiones del MOSSF-36 y del FIQ y discrepancias en cuanto a las dimensiones más afectadas 13,14 . Además, los estudios individuales presentan algunas limitaciones, que deben superarse, como las relacionadas con la validez externa de las conclusiones por presentar bajo tamaño de muestra o potencia estadística, no dar cuenta de diferencias relacionadas con el lugar de estudio o no presentar comparaciones entre los resultados del MOSSF-36 y del FIQ.…”